IADSA update on international supplement regulations

IADSA update on international supplement regulations

November 2020 IADSA Newsflash

Published: Monday, November 23, 2020

AHPA is an active member of IADSA and is distributing the IADSA Newsflash as a member benefit. IADSA is an association focused on the globalization of food supplement markets and regulatory challenges. This issue of the IADSA Newsflash covers:

  • China has issued three new technical guidelines related to health food – toxicological testing, safety testing of bacterial strains, and physicochemical and hygienic examination.
  • India is amending its supplement and food regulations, and has revised upward several recommended daily allowances (RDAs) for several vitamins and minerals.
  • Korea has introduced some changes to its health functional Food Code, including warning statements for some dietary constituents.
  • Australia has classified sports supplements under the Therapeutic Goods Administration (TGA).
  • A European Parliament committee has blocked the proposed revision to titanium dioxide specifications. The European Food Safety Authority (EFSA) is expected to release a safety assessment on titanium dioxide in March 2021.
  • The European Court determined that on-hold health claims can be made under the responsibility of food operators and with the support of scientifically valid evidence. Of the more than 2000 on-hold claims, many relate to herbal substances.
  • In addition to maximum levels for green tea and red yeast rice (monacolin K), the European Commission (EC) is considering warning statements.
  • The EC will be requesting an Article 8 assessment of Garcinia cambogia due to hepatic failure after consumption of the plant.
  • French Agency for Food, Environmental and Occupational Health & Safety, reviewed a case of acute hepatitis related to a food supplement containing powdered bark of Bauhinia variegata.
  • The United Kingdom updated its CBD guidance to clarify the need for toxicological information.
  • Ukraine has harmonized its regulations with EU regulations on health claims.

Download the November 2020 issue >>

Print

2022 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.